Abstract:An increasing number of artemisinin (ARS) and its derivatives have been reported for their potential therapeutic value of human cancer. However, their therapeutic potencies are limited owing to their poor pharmacokinetic profiles. Our previous studies showed that a lead compound ARS4 originated from incorporating the pharmacophore of the approved chemotherapeutic agent melphalan into the basic skeleton of artemisinin with a succinic linker exhibited an excellent toxicity to human ovarian cancer cells and low cytotoxicity to normal cells. The mechanism studies demonstrated that it inhibited the growth and proliferation of ovarian cancer cells and resulted in S-phase arrest, apoptosis and inhibition of migration. Meanwhile, it exhibited excellent antitumor activities in animal models. Herein, further structure optimization for this lead compound ARS4 was performed and nineteen novel derivatives were designed and synthesized. Among them, compounds 10-12, 15, 16, 18 and 19 demonstrated powerful cytotoxic effects against human liver cancer and ovarian cancer cell lines, with their IC50s below 0.86 μM against Hep3B and A2780 cell lines, which are superior to that of ARS4. Four compounds (11, 15, 16 and 18) were selected to further evaluate their antitumor activities in in vitro and in vivo ovarian and liver cancer models, the results indicated that compound 18 exhibited the best therapeutic effect, not only effectively inhibited the growth of 7404 xenograft and Huh7 xenograft, but also presented a good dose-dependent inhibition toward the growth of A2780 xenograft. Overall, based on these positive results, these novel chemical structures may provide a new inspiration for the discovery of novel antitumor agents originated from artemisinin scaffolds.

Design, Synthesis, and Antitumor Activities of Isomers of Artemisinin Dimer Derivatives

Front Cover: Design, Synthesis, and Antitumor Activities of Isomers of Artemisinin Dimer Derivatives (Chem. Biodiversity 7/2023)

[Design, Synthesis and Antiproliferative Activities of Artemisinin Derivatives Substituted by N-heterocycles].

Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties

Synthesis of Novel Ring-Contracted Artemisinin Dimers with Potent Anticancer Activities.

Synthesis and Anti-Tumor Effect of Artemisone Derivatives

Synthesis, X-ray Crystal Structure, DFT Calculation and Anti-Tumor Research of Novel-Configurational Dihydroartemisinin Purine Hybrids

Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents

Synthesis, crystal structure, DFT and anticancer study of dihydroartermisinin-paracetamol hybrids

[Design, Synthesis and Antiproliferative Activity in Cancer Cells of Novel Dihydropyrazolyl and Pyrazolyl Artemisinin-Phenyl Ethers].

Two-carbon Tethered Artemisinin–isatin Hybrids: Design, Synthesis, Anti-Breast Cancer Potential, and in Silico Study

Synthesis and in Vitro Antitumor Evaluation of Dihydroartemisinin-Cinnamic Acid Ester Derivatives.

Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers

Artemisinin-isatin Hybrids with Potential Antiproliferative Activity Against Breast Cancer

Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin‐Isatin Hybrids As Potent Anti‐Breast Cancer Agents

Synthesis And Anti-Tumor Activities Of Novel Artemisone-Piperazine-Sulfonamide Derivatives

Design, Synthesis and Antiproliferative Activities of Artemisinin Derivatives Containing A Substituted Piperazine

Design, synthesis, and in vitro and in vivo biological evaluation of dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties

Design, synthesis and biological evaluation of artemisinin derivatives containing fluorine atoms as anticancer agents.

Synthesis, Anticancer Evaluation and Pharmacokinetic Study of Novel 10-O-phenyl Ethers of Dihydroartemisinin

Novel Dihydroisoxazoline-Alkyl Carbon Chain Hybrid Artemisinin Analogues (artemalogs): Synthesis and Antitumor Activities